AI Analysis

Log in to generate an AI summary for this stock.

Log in to generate a MOAT report for this stock.

Log in to generate an earnings report for this stock.

Log in to generate an operating leverage report for this stock.

Log in to generate a management report for this stock.

Log in to generate a valuation report for this stock.

SurgLine International, Inc.

$0 +$0.00 (+0.00%)
OTC · 14 Sep 2026 20:00 UTC
Previous Close
$0
Day Range
$0$0
Year Range
$0$0
Market Cap
569.01K
AVG Volume
2.68M
Trailing/Forward PE
-0.2/-
PEG ratio
0.1
Dividend Yield
-
Next Earnings Date
-
Primary Exchange
Other OTCUS
Revenue (USD) · TTM
050K100K150K10 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
SGLN Revenue (USD) · TTM by quarter
PeriodRevenue (USD) · TTM
12 Q4113.62K
12 Q3119.16K
12 Q2103.15K
12 Q175.27K
11 Q40
11 Q30
11 Q20
11 Q10
10 Q40
10 Q33.17K
Net Income (USD) · TTM
-3M-2M-1M010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
SGLN Net Income (USD) · TTM by quarter
PeriodNet Income (USD) · TTM
12 Q4-2.74M
12 Q3-2.53M
12 Q2-2.42M
12 Q1-1.84M
11 Q4-225.32K
11 Q3-380.94K
11 Q2-713.79K
11 Q1-875.44K
10 Q4-772.06K
10 Q3-670.98K
Operating Income (USD) · TTM
-3M-2M-1M010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
SGLN Operating Income (USD) · TTM by quarter
PeriodOperating Income (USD) · TTM
12 Q4-2.08M
12 Q3-2.12M
12 Q2-2.13M
12 Q1-2.04M
11 Q4-354.03K
11 Q3-233.2K
11 Q2-245.3K
11 Q1-268.61K
10 Q4-392.68K
10 Q3-569.3K
EBITDA (USD) · TTM
-3M-2M-1M010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
SGLN EBITDA (USD) · TTM by quarter
PeriodEBITDA (USD) · TTM
12 Q4-2.45M
12 Q3-2.11M
12 Q2-2.12M
12 Q1-2.03M
11 Q4-354.03K
11 Q3-226.03K
11 Q2-230.97K
11 Q1-247.11K
10 Q4-364.01K
10 Q3-538.98K
Cash Flows (USD) · TTM
-400K-300K-200K-100K010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
SGLN Cash Flows (USD) · TTM by quarter
PeriodCash Flows (USD) · TTM
12 Q4-357.44K
12 Q3-352.26K
12 Q2-235.13K
12 Q1-147.02K
11 Q4-35.09K
11 Q3-22.12K
11 Q2-109.99K
11 Q1-69.72K
10 Q4-108.25K
10 Q3-164.89K
EPS (USD) · TTM
-0.04-0.03-0.02-0.01010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
SGLN EPS (USD) · TTM by quarter
PeriodEPS (USD) · TTM
12 Q4-0.01
12 Q3-0.01
12 Q2-0.01
12 Q1-0.01
11 Q4-0.01
11 Q3-0.01
11 Q2-0.02
11 Q1-0.03
10 Q4-0.03
10 Q3-0.03
Expenses (USD) · TTM
01M2M3MSG&ACapex10 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
SGLN Expenses (USD) · TTM by quarter
PeriodExpenses (USD) · TTM
12 Q42.12M
12 Q32.13M
12 Q22.13M
12 Q12.03M
11 Q4309.59K
11 Q3270.24K
11 Q2269.83K
11 Q1293.14K
10 Q4417.21K
10 Q3597.61K
Shares Outstanding · TTM
-2M-1.5M-1M-500K010 Q310 Q411 Q111 Q211 Q311 Q412 Q112 Q212 Q312 Q4
SGLN Shares Outstanding · TTM by quarter
PeriodShares Outstanding · TTM
12 Q4-1.58M
12 Q3-1.53M
12 Q2-1.55M
12 Q1-1.55M
11 Q4-20K
11 Q3-25.63K
11 Q2-11.72K
11 Q1-17.81K
10 Q4-123.91K
10 Q3-257.71K
Free Cash Flow Yield
-8000%-6000%-4000%-2000%0%med -66.85%Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SGLN Free Cash Flow Yield by quarter
PeriodFree Cash Flow Yield
Sep 26-66.85%
Sep 26-6685.13%
Aug 26-66.85%
Aug 26-66.85%
Aug 26-66.85%
Aug 26-66.85%
Jul 26-66.85%
Jul 26-66.85%
Jul 26-66.85%
Jul 26-66.85%
Jul 26-6685.13%
Jun 26-6685.13%
Jun 26-66.85%
Jun 26-66.85%
Jun 26-66.85%
May 26-66.85%
May 26-66.85%
May 26-66.85%
May 26-66.85%
May 26-66.85%
Apr 26-66.85%
Apr 26-66.85%
Apr 26-66.85%
Apr 26-66.85%
Mar 26-66.85%
Mar 26-66.85%
Mar 26-66.85%
Mar 26-66.85%
Feb 26-66.85%
Feb 26-66.85%
Feb 26-66.85%
Feb 26-6685.13%
Jan 26-66.85%
Jan 26-66.85%
Jan 26-66.85%
Jan 26-66.85%
Jan 26-66.85%
Dec 25-66.85%
Dec 25-66.85%
Dec 25-66.85%
Dec 25-66.85%
Nov 25-66.85%
Nov 25-66.85%
Nov 25-66.85%
Nov 25-66.85%
Oct 25-66.85%
Oct 25-66.85%
Oct 25-66.85%
Oct 25-66.85%
Oct 25-66.85%
Sep 25-66.85%
Sep 25-6685.13%
Sep 25-66.85%
Sep 25-66.85%
Aug 25-66.85%
Aug 25-66.85%
Aug 25-66.85%
Aug 25-66.85%
Aug 25-66.85%
Jul 25-66.85%
Jul 25-66.85%
Jul 25-66.85%
Jul 25-66.85%
Jun 25-66.85%
Jun 25-66.85%
Jun 25-66.85%
Jun 25-66.85%
May 25-66.85%
May 25-66.85%
May 25-66.85%
May 25-66.85%
May 25-66.85%
Apr 25-66.85%
Apr 25-66.85%
Apr 25-66.85%
Apr 25-66.85%
Mar 25-66.85%
Mar 25-66.85%
Mar 25-6685.13%
Mar 25-66.85%
Feb 25-66.85%
Feb 25-66.85%
Feb 25-66.85%
Feb 25-66.85%
Jan 25-66.85%
Jan 25-66.85%
Jan 25-66.85%
Jan 25-66.85%
Jan 25-66.85%
Dec 24-66.85%
Dec 24-66.85%
Dec 24-66.85%
Dec 24-66.85%
Nov 24-66.85%
Nov 24-66.85%
Nov 24-66.85%
Jun 23-6685.13%
May 23-6685.13%
May 23-6685.13%
Apr 23-6685.13%
Price to Sales
0246med 4.71Dec 24Apr 25Jul 25Oct 25Feb 26May 26Sep 26
SGLN Price to Sales by quarter
PeriodPrice to Sales
Sep 264.71
Sep 260.05
Aug 264.71
Aug 264.71
Aug 264.71
Aug 264.71
Jul 264.71
Jul 264.71
Jul 264.71
Jul 264.71
Jul 260.05
Jun 260.05
Jun 264.71
Jun 264.71
Jun 264.71
May 264.71
May 264.71
May 264.71
May 264.71
May 264.71
Apr 264.71
Apr 264.71
Apr 264.71
Apr 264.71
Mar 264.71
Mar 264.71
Mar 264.71
Mar 264.71
Feb 264.71
Feb 264.71
Feb 264.71
Feb 260.05
Jan 264.71
Jan 264.71
Jan 264.71
Jan 264.71
Jan 264.71
Dec 254.71
Dec 254.71
Dec 254.71
Dec 254.71
Nov 254.71
Nov 254.71
Nov 254.71
Nov 254.71
Oct 254.71
Oct 254.71
Oct 254.71
Oct 254.71
Oct 254.71
Sep 254.71
Sep 250.05
Sep 254.71
Sep 254.71
Aug 254.71
Aug 254.71
Aug 254.71
Aug 254.71
Aug 254.71
Jul 254.71
Jul 254.71
Jul 254.71
Jul 254.71
Jun 254.71
Jun 254.71
Jun 254.71
Jun 254.71
May 254.71
May 254.71
May 254.71
May 254.71
May 254.71
Apr 254.71
Apr 254.71
Apr 254.71
Apr 254.71
Mar 254.71
Mar 254.71
Mar 250.05
Mar 254.71
Feb 254.71
Feb 254.71
Feb 254.71
Feb 254.71
Jan 254.71
Jan 254.71
Jan 254.71
Jan 254.71
Jan 254.71
Dec 244.71
Dec 244.71
Dec 244.71
Dec 244.71
Nov 244.71
Nov 244.71
Nov 244.71
Jun 230.05
May 230.05
May 230.05
Apr 230.05
SurgLine International, Inc.
SGLN
Stockpicker

Video analysis: SGLN

All videos

No video analysis for this stock yet. Request one from our team.

Your email is used only to follow up on this request. We do not add you to marketing lists. Privacy Policy

Similar companies

Disclaimer: The historical data presented on this platform is provided by Financial Modeling Prep. Stock Picker is a platform for informational purposes only and does not provide financial advice. Users are encouraged to conduct their own research and consult with a qualified financial advisor before making investment decisions.